BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

Immunoinformatic evaluation of multiple epitope ensembles as vaccine candidates: E coli 536

 

Authors

Jade Rai, Ka In Lok, Chun Yin Mok, Harvinder Mann, Mohammed Noor, Pritesh Patel, & Darren R Flower*

 

Affiliation

Aston Pharmacy School, Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.

 

Email

D.R.Flower@aston.ac.uk; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received March 27, 2012; Accepted March 28, 2012; Published March 31, 2012

 

Abstract

Epitope prediction is becoming a key tool for vaccine discovery. Prospective analysis of bacterial and viral genomes can identify antigenic epitopes encoded within individual genes that may act as effective vaccines against specific pathogens. Since B-cell epitope prediction remains unreliable, we concentrate on T-cell epitopes, peptides which bind with high affinity to Major Histacompatibility Complexes (MHC). In this report, we evaluate the veracity of identified T-cell epitope ensembles, as generated by a cascade of predictive algorithms (SignalP, Vaxijen, MHCPred, IDEB, EpiJen), as a candidate vaccine against the model pathogen uropathogenic gram negative bacteria Escherichia coli (E-coli) strain 536 (O6:K15:H31). An immunoinformatic approach was used to identify 23 epitopes within the E-coli proteome. These epitopes constitute the most promiscuous antigenic sequences that bind across more than one HLA allele with high affinity (IC50 < 50nM). The reliability of software programmes used, polymorphic nature of genes encoding MHC and what this means for population coverage of this potential vaccine are discussed.

 

Citation

Rai et al. Bioinformation 8(6): 272-275 (2012)
 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.